Cited 0 time in
Current status of penile rehabilitation after radical prostatectomy
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Jae Heon | - |
| dc.contributor.author | Lee, Seung Wook | - |
| dc.date.accessioned | 2022-07-16T00:33:40Z | - |
| dc.date.available | 2022-07-16T00:33:40Z | - |
| dc.date.issued | 2015-02 | - |
| dc.identifier.issn | 2005-6737 | - |
| dc.identifier.issn | 2005-6745 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/157988 | - |
| dc.description.abstract | Although disease-free survival remains the primary goal of prostate cancer treatment, erectile dysfunction (ED) remains a common complication that affects the quality of life. Even though several preventive and therapeutic strategies are available for ED after radical prostatectomy (RP), no specific recommendations have been made on the optimal rehabilitation or treatment strategy. Several treatment options are available, including phosphodiesterase-5 inhibitors, vacuum erection devices, intracavernosal or intraurethral prostaglandin injections, and penile prostheses. Urologists must consider more effective ways to establish optimal treatments for ED after RP. ED is an important issue among patients with prostate cancer, and many patients hope for early ED recovery after surgery. This review highlights the currently available treatment options for ED after RP and discusses the limitations of each. | - |
| dc.format.extent | 10 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Korean Urological Association | - |
| dc.title | Current status of penile rehabilitation after radical prostatectomy | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.4111/kju.2015.56.2.99 | - |
| dc.identifier.scopusid | 2-s2.0-84922642293 | - |
| dc.identifier.bibliographicCitation | Korean Journal of Urology, v.56, no.2, pp 99 - 108 | - |
| dc.citation.title | Korean Journal of Urology | - |
| dc.citation.volume | 56 | - |
| dc.citation.number | 2 | - |
| dc.citation.startPage | 99 | - |
| dc.citation.endPage | 108 | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART001961349 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordPlus | growth factor | - |
| dc.subject.keywordPlus | immunophilin | - |
| dc.subject.keywordPlus | neurotrophin | - |
| dc.subject.keywordPlus | papaverine | - |
| dc.subject.keywordPlus | phentolamine | - |
| dc.subject.keywordPlus | phosphodiesterase V inhibitor | - |
| dc.subject.keywordPlus | prostaglandin | - |
| dc.subject.keywordPlus | prostaglandin E1 | - |
| dc.subject.keywordPlus | prostate specific antigen | - |
| dc.subject.keywordPlus | sildenafil | - |
| dc.subject.keywordPlus | tadalafil | - |
| dc.subject.keywordPlus | vardenafil | - |
| dc.subject.keywordPlus | vasodilator agent | - |
| dc.subject.keywordAuthor | Erectile dysfunction | - |
| dc.subject.keywordAuthor | Penis erection | - |
| dc.subject.keywordAuthor | Prostatectomy | - |
| dc.identifier.url | https://icurology.org/DOIx.php?id=10.4111/kju.2015.56.2.99 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
